SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 30, 1999
WESTMED VENTURE PARTNERS 2, L.P.
- -------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 13-3473015
- -------------------------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
CIBC Oppenheimer Tower, World Financial Center
New York, New York 10281
- -------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (212) 667-7000
<PAGE>
WESTMED VENTURE PARTNERS 2, L.P.
Item 5. Other Events.
In December 1999, WestMed Venture Management 2, L.P., the Managing General
Partner of the WestMed Venture Partners 2, L.P., approved a cash distribution
totaling $4,342,118 to be paid to Partners in January 2000. Limited Partners of
record on December 31, 1999 will receive $4,298,697, or $111 per unit of limited
partnership interest, and the General Partners will receive $43,421.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
WESTMED VENTURE PARTNERS 2, L.P.
By: WestMed Venture Management 2, L.P.
The Managing General Partner
By: MEDICAL VENTURE HOLDINGS, INC.
General Partner
By: /s/ Gerald A. Rothstein Date: January 4, 2000
--------------------------------------- ---------------
Gerald A. Rothstein
President and Principal Executive Officer
By: /s/ Ann Oliveri Fusco Date: January 4, 2000
----------------------------------------- ---------------
Ann Oliveri Fusco
Vice President and Principal Financial
and Accounting Officer
